About Centrum Medyczne Pulawska SP. z o.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Centrum Medyczne Pulawska SP. z o.o.
During the past decade, Centrum Medyczne Pulawska SP. z o.o. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration
2003-05-01
2006-09-01
Completed
426
Study of Medical Treatment of Low-Pressure (Normal Tension) Glaucoma
1998-12-01
2004-05-01
Completed
160
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-09-18
2018-01-29
Terminated
906
The American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)
2016-02-01
2020-09-30
Terminated
50
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
2016-07-21
2018-01-31
Terminated
994
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
2018-08-31
2023-01-30
Active, not recruiting
600
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
2018-10-09
2021-08-27
Completed
951
ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA
2019-03-27
2022-04-14
Completed
176
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Pulawska SP. z o.o."
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centrum Medyczne Pulawska SP. z o.o.
According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Pulawska SP. z o.o." are
"Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials), "Hemiretinal Vein Occlusion" (1 trials) and "Influenza" (1 trials). Many other conditions were trialed in "Centrum Medyczne Pulawska SP. z o.o." in a lesser frequency.
Clinical Trials Intervention Types at Centrum Medyczne Pulawska SP. z o.o.
Most popular intervention types in "Centrum Medyczne Pulawska SP. z o.o." are "Drug" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Aflibercept" (2 trials), "Faricimab" (2 trials), "Sham Procedure" (2 trials), "Baloxavir Marboxil" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centrum Medyczne Pulawska SP. z o.o.
The vast majority of trials in "Centrum Medyczne Pulawska SP. z o.o." are
3 trials for "All" genders.
Clinical Trials Status at Centrum Medyczne Pulawska SP. z o.o.
Currently, there are NaN active trials in "Centrum Medyczne Pulawska SP. z o.o.".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Centrum Medyczne Pulawska SP. z o.o.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Medyczne Pulawska SP. z o.o., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".